Insulin solubility transitions by pH‐dependent interactions with proinsulin C‐peptide

Proinsulin processing into insulin and C‐peptide in the secretory granules of the pancreatic β‐cells occurs under mildly acidic conditions and at high peptide concentrations (> 10 mm). Mature insulin has reduced solubility and a propensity to adopt an amyloid‐like structure, but is physiologically released as a mixture of a zinc‐containing core and a zinc‐free, C‐peptide‐rich fluid phase. C‐peptide is known to function in the insulin secretion, but its exact mode of interaction is not established. We now demonstrate that C‐peptide in sub‐stoichiometric amount versus insulin coprecipitates with insulin at the pH found in secretory vesicles. Precipitation is reversible and the precipitate is dissolved by elevation of the pH. This effect was found to be dependent on relatively conserved glutamate residues in the otherwise poorly conserved C‐peptide. Together, the data show that C‐peptide has the ability to influence insulin solubility. The physiological pH changes between insulin processing and release sites may therefore affect the quaternary structure of insulin, as well as the phase transitions during insulin sorting and secretion.

[1]  J. Johansson,et al.  Proinsulin C-peptide interferes with insulin fibril formation. , 2012, Biochemical and biophysical research communications.

[2]  T. Pedersen,et al.  Novel Covalently Linked Insulin Dimer Engineered to Investigate the Function of Insulin Dimerization , 2012, PloS one.

[3]  H. Jörnvall,et al.  N-terminal segment of proinsulin C-peptide active in insulin interaction/desaggregation. , 2010, Biochemical and biophysical research communications.

[4]  H. Jörnvall,et al.  Structural features of proinsulin C‐peptide oligomeric and amyloid states , 2010, The FEBS journal.

[5]  J. Johansson,et al.  Oligomerization and insulin interactions of proinsulin C-peptide: Threefold relationships to properties of insulin. , 2010, Biochemical and biophysical research communications.

[6]  B. Joseph,et al.  Proinsulin C-peptide Regulates Ribosomal RNA Expression* , 2009, The Journal of Biological Chemistry.

[7]  M. Granvik,et al.  Insulin crystallization depends on zinc transporter ZnT8 expression, but is not required for normal glucose homeostasis in mice , 2009, Proceedings of the National Academy of Sciences.

[8]  T. Chatake,et al.  An abnormal pK(a) value of internal histidine of the insulin molecule revealed by neutron crystallographic analysis. , 2008, Biochemical and biophysical research communications.

[9]  H. Jörnvall,et al.  C-peptide is a bioactive peptide , 2007, Diabetologia.

[10]  B. Joseph,et al.  Cellular internalization of proinsulin C-peptide , 2007, Cellular and Molecular Life Sciences.

[11]  K. Ekberg,et al.  Proinsulin C-peptide elicits disaggregation of insulin resulting in enhanced physiological insulin effects , 2006, Cellular and Molecular Life Sciences.

[12]  Robert H. Chow,et al.  Pancreatic β-Cells Secrete Insulin in Fast- and Slow-Release Forms , 2006 .

[13]  P. Carey,et al.  Proinsulin Is Refractory to Protein Fibrillation , 2005, Journal of Biological Chemistry.

[14]  Michael F. Dunn,et al.  Zinc–Ligand Interactions Modulate Assembly and Stability of the Insulin Hexamer – A Review , 2005, Biometals.

[15]  H. Kalbitzer,et al.  Solution structure of human proinsulin C‐peptide , 2005, The FEBS journal.

[16]  C. Dobson,et al.  Characterization of the oligomeric states of insulin in self-assembly and amyloid fibril formation by mass spectrometry. , 2000, Biophysical journal.

[17]  J. Johansson,et al.  Role of C-peptide in human physiology. , 2000, American journal of physiology. Endocrinology and metabolism.

[18]  J. Wahren,et al.  Beneficial effects of C‐peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[19]  G Kratz,et al.  Specific binding of proinsulin C-peptide to human cell membranes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  B. Ahrén,et al.  B cell granule peptides affect human islet amyloid polypeptide (IAPP) fibril formation in vitro. , 1997, Biochemical and biophysical research communications.

[21]  J. Brange,et al.  Toward understanding insulin fibrillation. , 1997, Journal of pharmaceutical sciences.

[22]  D. Steiner,et al.  Effects of beta cell granule components on human islet amyloid polypeptide fibril formation , 1996, FEBS letters.

[23]  J. Wahren,et al.  The influence of human C-peptide on renal function and glucose utilization in Type 1 (insulin-dependent) diabetic patients , 1992, Diabetologia.

[24]  H. Davidson,et al.  Intraorganellar calcium and pH control proinsulin cleavage in the pancreatic β cell via two distinct site-specific endopeptidases , 1988, Nature.

[25]  P. J. Watkins,et al.  Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient , 1988, Diabetologia.

[26]  D. Steiner,et al.  Studies on the molecular organization of rat insulin secretory granules. , 1987, The Journal of biological chemistry.

[27]  L. Orci,et al.  Conversion of proinsulin to insulin occurs coordinately with acidification of maturing secretory vesicles , 1986, The Journal of cell biology.

[28]  H. Kaplan,et al.  Structure-function relationships in the free insulin monomer. , 1986, The Biochemical journal.

[29]  D. Steiner.  Cocrystallization of Proinsulin and Insulin , 1973, Nature.

[30]  D. Steiner,et al.  Insulin Biosynthesis: Evidence for a Precursor , 1967, Science.

[31]  R. Chow,et al.  Pancreatic beta-cells secrete insulin in fast- and slow-release forms. , 2006, Diabetes.

[32]  D. Steiner.  The Proinsulin C-peptide—A Multirole Model , 2004, Experimental diabesity research.

[33]  Bruce H. Frank,et al.  Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. , 1986, The Journal of clinical investigation.